Safety and efficacy of metabolic modulation with ninerafaxstat in patients with nonobstructive hypertrophic cardiomyopathy

Authors

Martin S Maron, Lahey Hospital and Medical Center
Sharon Cresci, Washington University School of Medicine in St. Louis
et al.

Journal

Journal of the American College of Cardiology

Publication Date

5-28-2024

Volume

83

Issue

21

First Page

2037

Last Page

2048

Document Type

Open Access Publication

DOI

10.1016/j.jacc.2024.03.387

Rights and Permissions

Maron MS, Mahmod M, Abd Samat AH, Choudhury L, Massera D, Phelan DMJ, Cresci S, Martinez MW, Masri A, Abraham TP, Adler E, Wever-Pinzon O, Nagueh SF, Lewis GD, Chamberlin P, Patel J, Yavari A, Dehbi HM, Sarwar R, Raman B, Valkovič L, Neubauer S, Udelson JE, Watkins H. Safety and Efficacy of Metabolic Modulation With Ninerafaxstat in Patients With Nonobstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2024 May 28;83(21):2037-2048. doi: 10.1016/j.jacc.2024.03.387 This article is available under the Creative Commons CC-BY-NC-ND license and permits non-commercial use of the work as published, without adaptation or alteration provided the work is fully attributed.

Recommended Citation

Maron, Martin S; Cresci, Sharon; and et al., "Safety and efficacy of metabolic modulation with ninerafaxstat in patients with nonobstructive hypertrophic cardiomyopathy." Journal of the American College of Cardiology. 83, 21. 2037 - 2048. (2024).
https://digitalcommons.wustl.edu/oa_4/5373

Department

ICTS (Institute of Clinical and Translational Sciences)